EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H16FN5O4 |
| Net Charge | 0 |
| Average Mass | 397.366 |
| Monoisotopic Mass | 397.11863 |
| SMILES | O=C1NC(=O)N(CCc2ccc(F)cc2)C(=O)C1=CNNC(=O)c1ccncc1 |
| InChI | InChI=1S/C19H16FN5O4/c20-14-3-1-12(2-4-14)7-10-25-18(28)15(17(27)23-19(25)29)11-22-24-16(26)13-5-8-21-9-6-13/h1-6,8-9,11,22H,7,10H2,(H,24,26)(H,23,27,29) |
| InChIKey | KGCNNBPDTQBHKJ-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N'-[[1-[2-(4-fluorophenyl)ethyl]-2,4,6-trioxo-1,3-diazinan-5-ylidene]methyl]-4-pyridinecarbohydrazide (CHEBI:121322) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-32765 | LINCS |